Shandong sinoglory health food co.(603182)
Search documents
嘉华股份(603182) - 嘉华股份首次公开发行部分限售股上市流通公告
2025-09-03 10:16
重要内容提示: 本次股票上市类型为首发股份;股票认购方式为网下,上市股数为 71,471,328股。 证券代码:603182 证券简称:嘉华股份 公告编号:2025-023 山东嘉华生物科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本次股票上市流通总数为71,471,328股。 本次股票上市流通日期为2025 年 9 月 9 日。 一、本次限售股上市类型 根据中国证券监督管理委员会(以下简称"中国证监会")于 2022 年 8 月 15 日出具的《关于核准山东嘉华生物科技股份有限公司首次公开发行股票的批复》 (证监许可〔2022〕1830 号)核准,山东嘉华生物科技股份有限公司(以下简称 "嘉华股份"或"公司")首次向社会公众公开发行人民币普通股(A 股)41,140,000 股,并于 2022 年 9 月 9 日在上海证券交易所上市。首次公开发行完成后,公司总 股本增加至 164,550,000 股,其中有限售条件流通股股份数量为 123,410,000 股, 无限 ...
嘉华股份(603182) - 国泰海通证券股份有限公司关于山东嘉华生物科技股份有限公司首次公开发行部分限售股上市流通的核查意见
2025-09-03 10:16
国泰海通证券股份有限公司 关于山东嘉华生物科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司(以下简称"保荐机构"、"国泰海通")作为山东嘉 华生物科技股份有限公司(以下简称"嘉华股份"、"公司")首次公开发行股票并在 主板上市及持续督导的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证 券交易所上市公司自律监管指引第1号—规范运作》《上海证券交易所上市公司自律监管 指引第11号—持续督导》等相关法律法规及规范性文件的规定,对嘉华股份首次公开 发行部分限售股上市流通的事项进行了核查,核查情况如下: 一、本次限售股上市类型 三、本次限售股上市流通的有关承诺 1、公司原实际控制人吴洪祥、黄瑞华、张效伟、李广庆、贾辉、高泽林及吴洪 祥近亲属吴洪力、黄瑞华近亲属赵冬杰、赵珂欣、张效伟近亲属陈春佳承诺: "自发行人股票上市之日起三十六个月内,不转让或者委托他人管理本人直接 或者间接持有的发行人公开发行股票前已发行的股份,也不由发行人回购本人直接 或者间接持有的发行人公开发行股票前已发行的股份。因发行人进行权益分派等导 1 致本人直接持有发行人股份发生变化的,仍遵守上述规定。 所持 ...
嘉华股份约7147.13万股限售股将于9月9日起上市流通
Zhi Tong Cai Jing· 2025-09-03 10:13
Core Viewpoint - Jia Hua Co., Ltd. (603182.SH) announced the release of restricted shares from its initial public offering, involving a total of approximately 71.47 million shares, which accounts for 43.43% of the company's total share capital [1] Summary by Relevant Categories Shareholder Information - The restricted shares involve a total of 11 shareholders [1] - The lock-up period for these shareholders is set for 36 months from the date of the stock listing [1] Future Trading - The restricted shares will become tradable starting from September 9, 2025 [1]
嘉华股份(603182.SH)约7147.13万股限售股将于9月9日起上市流通
智通财经网· 2025-09-03 10:02
Group 1 - The company Jia Hua Co., Ltd. (603182.SH) announced the release of restricted shares from its initial public offering, involving a total of approximately 71.47 million shares, which accounts for 43.43% of the company's total share capital [1] - The shareholders involved in this release consist of a total of 11 parties, and the lock-up period for these shares is set for 36 months from the date of the stock's listing [1] - The restricted shares will become tradable starting from September 9, 2025 [1]
农产品加工板块8月29日涨0.17%,索宝蛋白领涨,主力资金净流入5760.14万元
Zheng Xing Xing Ye Ri Bao· 2025-08-29 08:34
Market Overview - On August 29, the agricultural processing sector rose by 0.17% compared to the previous trading day, with Sobao Protein leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] Stock Performance - Sobao Protein (603231) closed at 19.59, with a significant increase of 9.99% and a trading volume of 195,100 shares, amounting to a transaction value of 367 million yuan [1] - Other notable performers included: - Jinlongyu (666000E) at 33.66, up 3.47%, with a transaction value of 1.038 billion yuan [1] - Yizhi Magic Hand (839273) at 47.42, up 2.89%, with a transaction value of 135.2 million yuan [1] - Huazi Industrial (600191) at 8.81, up 2.20%, with a transaction value of 10.3 million yuan [1] Capital Flow - The agricultural processing sector saw a net inflow of 57.6014 million yuan from institutional investors, while retail investors experienced a net outflow of 19.2071 million yuan [2] - The capital flow for key stocks included: - Sobao Protein had a net inflow of 82.9185 million yuan from institutional investors, but a net outflow of 48.5839 million yuan from retail investors [3] - Jinlongyu experienced a net inflow of 78.3111 million yuan from institutional investors, with a net outflow of 72.0730 million yuan from retail investors [3] - Baolingbao (002286) had a net inflow of 13.2288 million yuan from institutional investors, while retail investors saw a net outflow of 9.2370 million yuan [3]
嘉华股份(603182) - 嘉华股份关于召开2025年半年度业绩说明会的公告
2025-08-22 08:01
证券代码:603182 证券简称:嘉华股份 公告编号:2025-022 山东嘉华生物科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 投资者可于 2025 年 08 月 27 日 (星期三) 至 09 月 02 日 (星期二)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 sinoglory@sinoglorygroup.com 进行提问。公司将在说明会上对投资者普遍关 注的问题进行回答。 山东嘉华生物科技股份有限公司(以下简称"公司")已于 2025 年 8 月 20 日发布公司 2025 年半年度报告,为便于广大投资者更全面深入地了解公司 2025 年半年度经营成果、财务状况,公司计划于 2025 年 09 月 03 日 (星期三) 09:00-10:00 举行 2025 年半年度业绩说明会,就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开,公司将针对 2025 年半年度的经营 成果及 ...
嘉华股份2025年中报简析:净利润同比增长7.79%,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-20 22:31
Core Viewpoint - 嘉华股份 (603182) reported a decline in total revenue for the first half of 2025, while net profit increased, indicating a mixed financial performance with improved profitability metrics despite lower sales [1] Financial Performance Summary - Total revenue for H1 2025 was 681 million yuan, a decrease of 12.86% year-on-year [1] - Net profit attributable to shareholders was 62.29 million yuan, an increase of 7.79% year-on-year [1] - Gross margin improved to 16.0%, up 21.23% year-on-year, while net margin rose to 9.15%, an increase of 23.7% year-on-year [1] - Operating cash flow per share significantly decreased to 0.02 yuan, down 92.51% year-on-year [1] Expense and Asset Management - Total selling, administrative, and financial expenses amounted to 16.73 million yuan, accounting for 2.46% of revenue, which is a 41.74% increase year-on-year [1] - Cash and cash equivalents decreased by 58.31% to 75.32 million yuan, primarily due to loan repayments and the maturity of bank acceptance bills [1][2] - Accounts receivable dropped by 49.20% to 92.33 million yuan [1] Changes in Liabilities and Other Financial Metrics - Short-term borrowings and accounts payable both saw a 100% decrease, indicating repayment of debts [3] - The company’s return on invested capital (ROIC) was 9.79%, which is considered average, with historical median ROIC at 16.36% [5] - The ratio of cash to current liabilities was 86.55%, suggesting potential liquidity concerns [6]
嘉华股份2025上半年营收下滑12.86%,存货周转效率承压
Sou Hu Cai Jing· 2025-08-20 03:05
Core Viewpoint - Jia Hua Co., Ltd. reported a decline in revenue but an increase in profit for the first half of 2025, indicating a mixed performance in its operations [1][3]. Financial Performance - The company achieved an operating revenue of 681 million yuan, a year-on-year decrease of 12.86% [1]. - The net profit attributable to shareholders was 62 million yuan, reflecting a year-on-year growth of 7.79% [1]. - The net profit margin improved from 7.39% in the first half of 2024 to 9.15% in 2025 [3]. - The gross profit margin increased from 13.20% to 16.00% [3]. - The return on equity was 5.64%, with a year-on-year increase of 0.12 percentage points, indicating overall improvement in profitability quality [3]. Operational Efficiency - The inventory turnover days increased to 71.22 days, up by 11.22% compared to the first half of 2024, suggesting increased pressure on inventory management [5]. - The net cash flow from operating activities was 4 million yuan, a significant decline from 54 million yuan in the same period of 2024 [5]. - The debt-to-asset ratio for the first half of 2025 was 17.89%, a decrease of 5.59 percentage points year-on-year, indicating a lighter debt burden and a more stable financial structure [5]. Institutional Holdings - As of the first half of 2025, the number of institutions holding Jia Hua Co., Ltd. shares decreased to 3, down from 50 in the same period of 2024, showing a significant decline in institutional investor participation [7]. - The company's market capitalization peaked at 4.015 billion yuan on September 19, 2022, while the current market cap stands at 2.370 billion yuan, indicating a need for a 69.44% increase in stock price to reach its historical high [7]. - Despite the decline in institutional interest, the company has shown positive changes in profitability quality and financial structure [7].
嘉华股份:8月18日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-19 23:45
Group 1 - The core point of the article is that Jiahua Co., Ltd. announced the convening of its sixth fifth board meeting to review the semi-annual report for 2025 [1] - The meeting took place on August 18, 2025, and was conducted in a hybrid format combining in-person and communication methods [1] - Jiahua Co., Ltd. reported that its revenue composition for the year 2024 is as follows: food accounts for 92.41%, steam and electricity for 7.31%, and other businesses for 0.28% [1] Group 2 - As of the report, Jiahua Co., Ltd. has a market capitalization of 2.4 billion yuan [1]
嘉华股份:2025年半年度净利润约6229万元,同比增加7.79%
Mei Ri Jing Ji Xin Wen· 2025-08-19 23:05
Core Insights - The company reported a decrease in revenue for the first half of 2025, amounting to approximately 681 million yuan, which represents a year-on-year decline of 12.86% [2] - The net profit attributable to shareholders increased to approximately 62.29 million yuan, reflecting a year-on-year growth of 7.79% [2] - Basic earnings per share rose to 0.38 yuan, marking an increase of 8.57% compared to the previous year [2]